Literature DB >> 7341754

A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits.

S C Miller, K J Himmelstein, T F Patton.   

Abstract

This report presents a mathematical model which has been developed to describe the intraocular disposition of pilocarpine following topical dosing in rabbits. The model uses experimentally determined parameters such as rates of tissue uptake of drug and equilibrium distribution coefficients. Differential mass balance equations for pilocarpine in the cornea, aqueous humor, iris-ciliary body, and lens were written and solved numerically. Measured tear concentrations, following topical dosing wih pilocarpine, were fit by a monoexponential curve and used as the forcing function of the model. By using a combination of known physiological and experimentally determined parameters, predictions of intraocular tissue levels of pilocarpine were made. These predictions were then compared to experimentally determined concentration-time profiles.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7341754     DOI: 10.1007/bf01070899

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  12 in total

1.  Quantitative determination of uveal blood flow in rabbits.

Authors:  A BILL
Journal:  Acta Physiol Scand       Date:  1962 Jun-Jul

2.  Pediatric dosing considerations in ophthalmology--dosage adjustments based on aqueous humor volume ratio.

Authors:  T F Patton
Journal:  J Pediatr Ophthalmol       Date:  1977 Jul-Aug

3.  Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume.

Authors:  T F Patton
Journal:  J Pharm Sci       Date:  1977-07       Impact factor: 3.534

4.  Lacrimal and instilled fluid dynamics in rabbit eyes.

Authors:  S S Chrai; T F Patton; A Mehta; J R Robinson
Journal:  J Pharm Sci       Date:  1973-07       Impact factor: 3.534

5.  Corneal permeation of topical pilocarpine nitrate in the rabbit.

Authors:  S S Chrai; J R Robinson
Journal:  Am J Ophthalmol       Date:  1974-05       Impact factor: 5.258

6.  Kinetics of the hydrolysis of pilocarpine in aqueous solution.

Authors:  P H Chung; T F Chin; J L Lach
Journal:  J Pharm Sci       Date:  1970-09       Impact factor: 3.534

7.  Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.

Authors:  K J Himmelstein; I Guvenir; T F Patton
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

8.  Age-related differences in ophthalmic drug disposition I. Effect of size on the intraocular tissue distribution of pilocarpine in albino rabbits.

Authors:  S C Miller; T F Patton
Journal:  Biopharm Drug Dispos       Date:  1981 Jul-Sep       Impact factor: 1.627

9.  Pilocarpine ocular distribution volume.

Authors:  S C Miller; R D Gokhale; T F Patton; K J Himmelstein
Journal:  J Pharm Sci       Date:  1980-05       Impact factor: 3.534

10.  Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.

Authors:  V H Lee; J R Robinson
Journal:  J Pharm Sci       Date:  1979-06       Impact factor: 3.534

View more
  10 in total

1.  Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.

Authors:  C S Rao; R D Schoenwald; C F Barfknecht; S L Laban
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

2.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

Review 3.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

4.  Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids.

Authors:  Sudharshan Hariharan; Sriram Gunda; Gyan P Mishra; Dhananjay Pal; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

5.  Ocular pharmacokinetic models of clonidine-3H hydrochloride.

Authors:  C H Chiang; R D Schoenwald
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

6.  Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells.

Authors:  Veli-Pekka Ranta; Mirka Laavola; Elisa Toropainen; Kati-Sisko Vellonen; Anu Talvitie; Arto Urtti
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

7.  Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.

Authors:  Suresh Katragadda; Sriram Gunda; Sudharshan Hariharan; Ashim K Mitra
Journal:  Int J Pharm       Date:  2008-03-22       Impact factor: 5.875

8.  Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system.

Authors:  A Zimmer; E Mutschler; G Lambrecht; D Mayer; J Kreuter
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

9.  Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes.

Authors:  D S Chien; R D Schoenwald
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

10.  Distribution of Small Molecular Weight Drugs into the Porcine Lens: Studies on Imaging Mass Spectrometry, Partition Coefficients, and Implications in Ocular Pharmacokinetics.

Authors:  Emma M Heikkinen; Seppo Auriola; Veli-Pekka Ranta; Nicholas J Demarais; Angus C Grey; Eva M Del Amo; Elisa Toropainen; Kati-Sisko Vellonen; Arto Urtti; Marika Ruponen
Journal:  Mol Pharm       Date:  2019-08-08       Impact factor: 4.939

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.